Literature DB >> 1653264

Evaluation of a synthetic-peptide enzyme-linked immunosorbent assay for immunoglobulin M to human parvovirus B19.

E Fridell1, B J Cohen, B Wahren.   

Abstract

A synthetic peptide corresponding to a part of the virus protein 1-virus protein 2 overlapping region of human parvovirus B19 was used in an indirect enzyme-linked immunosorbent assay. Antibodies of the immunoglobulin (Ig) M class were measured in serum samples from patients with erythema infectiosum and controls. In comparison with an IgM assay using native B19 viral antigen, the peptide antigen assay was 92% sensitive and 87% specific. B19 IgM reactivities were seen in a limited number of children with other viral diseases. Specific IgM reactivities to short synthetic viral peptides have previously been reported only with Epstein-Barr virus. Since other sources of viral antigen are limited, the peptide antigen assay may be a useful alternative for the diagnosis of B19-associated disease in human beings.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1653264      PMCID: PMC270121          DOI: 10.1128/jcm.29.7.1376-1381.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  35 in total

1.  A new peptide for human parvovirus B19 antibody detection.

Authors:  E Fridell; J Trojnar; B Wahren
Journal:  Scand J Infect Dis       Date:  1989

2.  Expression of the human parvovirus B19 protein fused to protein A in Escherichia coli: recognition by IgM and IgG antibodies in human sera.

Authors:  F Morinet; L D'Auriol; J D Tratschin; F Galibert
Journal:  J Gen Virol       Date:  1989-11       Impact factor: 3.891

3.  An amplified ELISA for the detection of parvovirus B19 IgM using monoclonal antibody to FITC.

Authors:  K E Brown; M M Buckley; B J Cohen; D Samuel
Journal:  J Virol Methods       Date:  1989-11       Impact factor: 2.014

4.  Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis.

Authors:  R O Shade; M C Blundell; S F Cotmore; P Tattersall; C R Astell
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

5.  Human parvovirus B19 infection in pregnancy.

Authors:  T F Schwarz; M Roggendorf; B Hottenträger; F Deinhardt; G Enders; K P Gloning; T Schramm; M Hansmann
Journal:  Lancet       Date:  1988-09-03       Impact factor: 79.321

6.  A genetically engineered cell line that produces empty capsids of B19 (human) parvovirus.

Authors:  S Kajigaya; T Shimada; S Fujita; N S Young
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

7.  Incidence of sand fly fever among Swedish United Nations soldiers on Cyprus during 1985.

Authors:  R Eitrem; S Vene; B Niklasson
Journal:  Am J Trop Med Hyg       Date:  1990-08       Impact factor: 2.345

8.  Fetal pathology in human parvovirus B19 infection.

Authors:  A M Van Elsacker-Niele; M M Salimans; H T Weiland; C Vermey-Keers; M J Anderson; J Versteeg
Journal:  Br J Obstet Gynaecol       Date:  1989-07

9.  Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures.

Authors:  K Ozawa; N Young
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

10.  Parvovirus-like particles in human sera.

Authors:  Y E Cossart; A M Field; B Cant; D Widdows
Journal:  Lancet       Date:  1975-01-11       Impact factor: 79.321

View more
  7 in total

1.  Evaluation of antibodies against a rubella virus neutralizing domain for determination of immune status.

Authors:  P Cordoba; A Lanoel; S Grutadauria; M Zapata
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

2.  Epitope mapping of B-cell determinants on the 15-kilodalton lipoprotein of Treponema pallidum (Tpp15) with synthetic peptides.

Authors:  R E Baughn; M Demecs; L H Taber; D M Musher
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Evaluation of five commercial tests for detection of immunoglobulin M antibodies to human parvovirus B19.

Authors:  A L Bruu; S A Nordbø
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

4.  Does parvovirus B19 have a role in rheumatoid arthritis?

Authors:  S Nikkari; R Luukkainen; T Möttönen; O Meurman; P Hannonen; M Skurnik; P Toivanen
Journal:  Ann Rheum Dis       Date:  1994-02       Impact factor: 19.103

5.  Peptide-based OspC enzyme-linked immunosorbent assay for serodiagnosis of Lyme borreliosis.

Authors:  M J Mathiesen; M Christiansen; K Hansen; A Holm; E Asbrink; M Theisen
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

6.  Mapping of B-cell determinants in the nucleocapsid protein of Puumala virus: definition of epitopes specific for acute immunoglobulin G recognition in humans.

Authors:  A Lundkvist; S Björsten; B Niklasson; N Ahlborg
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

7.  Development & standardization of an in-house IgM indirect ELISA for the detection of parvovirus B19 infections.

Authors:  Kumaran Vadivel; Mageshbabu Ramamurthy; Sathish Sankar; Amita Jain; Padma Srikanth; Asit Ranjan Ghosh; Balaji Nandagopal; Aravindan Nair; Gopalan Sridharan
Journal:  Indian J Med Res       Date:  2017-09       Impact factor: 2.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.